Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2010-07-28

FDA Approved: LASTACAFT — Original Application (Allergan, Inc.)

View source ↗

Summary

FDA approved LASTACAFT (alcaftadine) from Allergan in an original application. It is indicated for relief of ocular itching associated with allergic conjunctivi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lastacaft (Alcaftadine)

Snippet

ORIG AP for LASTACAFT (ALCAFTADINE)